2390 EAST ORANGEWOOD AVENUE, ANAHEIM, CA
Market cap: $7.6M (12/25/2025)
Price: $0.40
News, Securities Holder Rights or Indentures, Material Contracts
Announces that it has acquired LUCEMYRA® (lofexidine), an FDA-Approved Opioid Withdrawal Medication, from USWM, LLC
News, Letter Re Change in Certifying Accountant
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Changes in Board, Management or Compensation
Material Contracts, Unregistered Sales of Equity Securities
Q3
Q2
Q1
FY 2024
FY 2023
RW
S-1
Effectiveness Notice
Amended Registration Statement for Securities
Registration Statement for Securities to be Offered to Employees
Notice of Exempt Offering of Securities
Definitive Information Statement
PRER14C
Preliminary Information Statement
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Confidential Treatment Order
S-8 POS